254. Porphyria Clinical trials / Disease details

Clinical trials : 72 / Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01284946 (ClinicalTrials.gov)	January 2011	26/1/2011	Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda	A Phase II, Open Label Clinical Trial Exploring the Safety and the Efficacy of Oral Deferasirox in Patients Newly Diagnosed With Porphyria Cutanea Tarda (PCT) and Non-transfusion Iron Overload	Porphyria Cutanea Tarda	Drug: Exjade	Assistance Publique - Hôpitaux de Paris	Association pour l'Etude des Fonctions Digestives (AEFD)	Recruiting	18 Years	N/A	Both	45	Phase 2	France
2	NCT00599326 (ClinicalTrials.gov)	January 2008	10/1/2008	Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda	Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda	Porphyria Cutanea Tarda	Drug: Deferasirox	University of Texas Southwestern Medical Center	Novartis Pharmaceuticals	Completed	18 Years	N/A	All	10	Phase 3	United States